There are 14 resources available
Welcome and Introduction
Presenter: Tony S. K. Mok, HKSAR CN and Solange Peters, CH
Session: Welcome and introduction
Resources:
Slides
Webcast
Biomarkers testing for NSCLC: Why should it be comprenhensive and/or reflex?
Presenter: Keith M. Kerr, UK
Session: Session 1 - Diagnosis and early detetction
Resources:
Slides
Webcast
The role of liquid biopsy in management of EGFR M+ lung cancer: Initial diagnosis, monitoring and resistance
Presenter: Molly S. C. Li, HKSAR CN
Session: Session 1 - Diagnosis and early detetction
Resources:
Slides
Webcast
Early detection of lung cancer among never smokers
Presenter: Pan-Chyr Yang, TW
Session: Session 1 - Diagnosis and early detetction
Resources:
Slides
Webcast
The art of optimal first-line therapy for patients with sensitizing or uncommon EGFR M+ lung cancer
Presenter: Tony S. K. Mok, HKSAR CN
Session: Session 2 - Optimal standard of Care
Resources:
Slides
Webcast
Potential combination therapy for EGFR M+ lung cancer
Presenter: Rina Hui, HKSAR CN
Session: Session 2 - Optimal standard of Care
Resources:
Slides
Webcast
Understanding and overcoming resistance to EGFR TKI: Mechanisms and dynamics
Presenter: David Planchard, FR
Session: Session 3 - EGFR TKI resistsnce
Resources:
Slides
Webcast
Treatment strategy for management of EGFR TKI resistance
Presenter: Lyudmila Bazhenova, US
Session: Session 3 - EGFR TKI resistsnce
Resources:
Slides
Webcast
Adjuvant therapy for resectable EGFR M+ lung cancer
Presenter: Thomas Y.-L. Wu, CN
Session: Session 4 - Early EGFR M+ NSCLC
Resources:
Slides
Webcast
How to manage stage III EGFR M+ lung cancer
Presenter: Suresh S. Ramalingam, US
Session: Session 4 - Early EGFR M+ NSCLC
Resources:
Slides
Webcast